Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenxiong Qingnao Yizhi Formula is a Traditional Chinese Medicine (TCM) decoction specifically developed for the treatment of vascular dementia. The formula is a combination of several botanical extracts, most notably *Salvia miltiorrhiza* (Danshen) and *Ligusticum chuanxiong* (Chuanxiong), which are traditionally utilized to promote blood circulation and resolve blood stasis. It also incorporates herbs like *Alpinia oxyphylla* and *Acorus tatarinowii* to support cognitive function and neuroprotection. The therapeutic mechanism involves enhancing cerebral blood flow, mitigating neuroinflammation, and protecting neurons from ischemic injury. It is currently under clinical investigation at the Shenzhen Traditional Chinese Medicine Hospital.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenxiong Qingnao Yizhi Formula.